Treatment

JADPRO: Palliative Care in Multiple Myeloma

The Journal of the Advanced Practitioner in Oncology (JADPRO) addresses effective treatments for multiple myeloma (MM), where many patients are maintained longer on chronic therapy and thus have greater need for palliative care to manage symptoms of the disease and side effects of therapy. Although some patients and health-care providers view palliative care as having a role only at the end of life, ideally this should begin at diagnosis and continue throughout the course of the disease.

Donna D. Catamero

ANP-BC, OCN, CCRC
Associate Director, Multiple Myeloma Research Program

Practical Guidance for New Multiple Myeloma Treatments: A Nursing Perspective

Currently, multiple targeted therapies are available to treat patients augmenting the arsenal of modalities which also includes chemotherapy, radiation therapy, and more. This review presents a summary of the evolution...

Limiting Early Mortality: Managing Patients with Newly Diagnosed Multiple Myeloma

Multiple myeloma (MM) survival continues to improve, but population-level data indicate that early mortality remains a substantial barrier to advances in MM outcomes. Recommendations are made for management may minimize...

FDA-Approved Multiple Myeloma Medications

Multiple myeloma (MM) treatments have evolved over the last thirty years, and drugs include proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents, corticosteroids, bisphosphonates, and monoclonal antibodies (MAbs). Since 2009,...

Role of Bone-Modifying Agents in Multiple Myeloma

An update panel conducted a targeted systematic literature review by searching PubMed and the Cochrane Library for randomized controlled trials, systematic reviews, meta-analyses, clinical practice guidelines, and observational studies.Thirty-five relevant...

Myeloma NED Talk 2021

Beth Faiman, Donna Catamero, Charise Gleason, and Tiffany Richards deliver NED talks on managing multiple myeloma, from Clinical Care Options (CCO)....

JADPRO Roundtable Series

In this video roundtable discussion, moderator Beth Faiman and her colleagues weigh in on what advanced practitioners need to know about the available administration options in the multiple myeloma (MM)...